CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $677 | -71.1% | 24,832 | -76.4% | 0.01% | -68.4% |
Q2 2023 | $2,339 | +91.4% | 105,110 | +86.3% | 0.02% | +90.0% |
Q1 2023 | $1,222 | +44.4% | 56,409 | +35.4% | 0.01% | -16.7% |
Q4 2022 | $846 | -99.8% | 41,654 | +116.8% | 0.01% | +100.0% |
Q2 2022 | $457,000 | -76.9% | 19,210 | -78.1% | 0.01% | -76.0% |
Q1 2022 | $1,976,000 | +29.6% | 87,754 | +13.9% | 0.02% | +56.2% |
Q4 2021 | $1,525,000 | +263.1% | 77,027 | +379.8% | 0.02% | +300.0% |
Q4 2020 | $420,000 | -44.7% | 16,053 | -63.2% | 0.00% | -73.3% |
Q3 2020 | $759,000 | +69.0% | 43,590 | +17.4% | 0.02% | +87.5% |
Q4 2019 | $449,000 | +43.9% | 37,139 | +68.3% | 0.01% | -27.3% |
Q3 2019 | $312,000 | – | 22,065 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |